Distinguished in Acute Coronary Syndrome

Diana A. Gorog

East And North Hertfordshire NHS Trust
Stevenage, ENG, GB 
Distinguished in Acute Coronary Syndrome
East And North Hertfordshire NHS Trust
Stevenage, ENG, GB 
OverviewLocationsClinical Research

Overview

Diana Gorog practices in Stevenage, United Kingdom. Ms. Gorog is rated as a Distinguished expert by MediFind in the treatment of Acute Coronary Syndrome. Her top areas of expertise are Acute Coronary Syndrome, Heart Attack, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Her clinical research consists of co-authoring 191 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 46 articles in the study of Acute Coronary Syndrome.

Gender
Female

Locations

East and North Hertfordshire NHS Trust
Stevenage, ENG, United Kingdom
Other Locations
Coreys Mill Lane, Stevenage, ENG, United Kingdom
Dovehouse Street, London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Comparison of Optimal Hypertension Regimens (Part of the Ancestry Informative Markers in Hypertension (AIMHY) Programme - AIMHY-INFORM)
Comparison of Optimal Hypertension Regimens (Part of the Ancestry Informative Markers in Hypertension (AIMHY) Programme - AIMHY-INFORM)
Enrollment Status: Completed
Publish Date: September 05, 2025
Intervention Type: Drug
Study Drugs: Amlodipine, Lisinopril, Amiloride, Chlortalidone
Study Phase: Phase 4
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
A Phase 3, Multicenter, Open-Label, Single-Arm Study of Bentracimab (PB2452) in Ticagrelor-Treated Patients With Uncontrolled Major or Life-Threatening Bleeding or Requiring Urgent Surgery or Invasive Procedure (REVERSE-IT Trial)
Enrollment Status: Completed
Publish Date: October 21, 2024
Intervention Type: Drug
Study Phase: Phase 3
CAN REMOTE ISCHAEMIC CONDITIONING REDUCE INFLAMMATORY MARKERS IN COVID-19 PATIENTS - A MULTI-SITE, RANDOMISED PILOT STUDY
CAN REMOTE ISCHAEMIC CONDITIONING REDUCE INFLAMMATORY MARKERS IN COVID-19 PATIENTS - A MULTI-SITE, RANDOMISED PILOT STUDY
Enrollment Status: Completed
Publish Date: November 29, 2023
Intervention Type: Other, Procedure
Study Phase: Not Applicable
Assessment of Thrombotic Status in Patients at Risk of Cardiovascular Thrombosis
Assessment of Thrombotic Status in Patients at Risk of Cardiovascular Thrombosis
Enrollment Status: Completed
Publish Date: February 08, 2019
Intervention Type: Diagnostic test
View 3 Less Clinical Trials

191 Total Publications

Optimizing risks and benefits of dual antiplatelet therapy after ACS: a winding path to precision.
Optimizing risks and benefits of dual antiplatelet therapy after ACS: a winding path to precision.
Journal: Future cardiology
Published: December 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gorog's expertise for a condition
ConditionClose
    View All 7 Advanced Conditions
    View All 29 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile